(HART) IQ Healthy Hearts - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US45409B3217

Healthcare Stocks, Pharmaceuticals, Medical Devices, Biotechnology

Description: HART IQ Healthy Hearts

The IQ Healthy Hearts ETF (NYSE ARCA: HART) is a passively managed exchange-traded fund designed to replicate the performance of an index developed by IndexIQ LLC, with Candriam, an affiliate of IndexIQ, serving as the index consultant. The fund tracks an index that includes equities of various market capitalizations—large-, mid-, and small-cap companies—trading in both U.S. and international markets, excluding certain emerging markets such as China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia, and the United Arab Emirates. As a non-diversified fund, it may concentrate its investments in a smaller number of securities, which can lead to higher volatility compared to diversified funds.

Ticker Symbol: HART | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Health

Based on the provided data, HART currently trades at $31.05, with a 20-day average volume of 1200 shares. Its short-term moving averages (SMA 20: $31.85, SMA 50: $32.02) suggest recent price stability, while the 200-day SMA ($31.71) indicates a slightly lower long-term trend. The Average True Range (ATR) of 0.25 reflects low volatility, suggesting minimal price fluctuations. The funds assets under management (AUM) stand at $9.32 million, a relatively small size for an ETF, which may impact liquidity.

3-Month Forecast: - - The funds moving averages (SMA 20: $31.85, SMA 50: $32.02, SMA 200: $31.71) suggest a potential sideways trend in the near term. - The low ATR of 0.25 indicates that volatility is likely to remain subdued. - The small average volume of 1200 shares could lead to limited market impact but may also result in wider bid-ask spreads. - - - With an AUM of $9.32 million, the funds liquidity may remain constrained, which could affect its ability to track the underlying index closely. - As a non-diversified fund, HART may exhibit heightened sensitivity to sector-specific developments in the healthcare industry. - Overall, HART is expected to maintain its current trajectory, with minimal price movement and low volatility. However, its non-diversified nature and small AUM may make it more susceptible to market conditions and sector-specific news.

Additional Sources for HART ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

HART ETF Overview

Market Cap in USD 9m
Category Health
TER 0.45%
IPO / Inception 2021-01-14

HART ETF Ratings

Growth Rating 27.9
Fundamental -
Dividend Rating 50.5
Rel. Strength -13.8
Analysts -
Fair Price Momentum 28.06 USD
Fair Price DCF -

HART Dividends

Dividend Yield 12m 1.52%
Yield on Cost 5y 1.98%
Annual Growth 5y 6.91%
Payout Consistency 100.0%
Payout Ratio %

HART Growth Ratios

Growth Correlation 3m 66.4%
Growth Correlation 12m -61.4%
Growth Correlation 5y 80.2%
CAGR 5y 5.68%
CAGR/Max DD 5y 0.33
Sharpe Ratio 12m 0.87
Alpha -11.65
Beta 0.573
Volatility 12.87%
Current Volume 0.3k
Average Volume 20d 0.2k
Stop Loss 29.2 (-3.4%)
What is the price of HART shares?
As of July 12, 2025, the stock is trading at USD 30.22 with a total of 298 shares traded.
Over the past week, the price has changed by +0.56%, over one month by -0.25%, over three months by +3.27% and over the past year by -2.14%.
Is IQ Healthy Hearts a good stock to buy?
Neither. Based on ValueRay´s Analyses, IQ Healthy Hearts is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.85 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HART is around 28.06 USD . This means that HART is currently overvalued and has a potential downside of -7.15%.
Is HART a buy, sell or hold?
IQ Healthy Hearts has no consensus analysts rating.
What are the forecasts for HART share price target?
According to our own proprietary Forecast Model, HART IQ Healthy Hearts will be worth about 31.7 in July 2026. The stock is currently trading at 30.22. This means that the stock has a potential upside of +5%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.7 5%